The Coronavirus Disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), poses unique challenges to healthcare systems worldwide. Among vulnerable populations, individuals with hematological and oncological diseases have drawn particular attention because...
As a result of advancements in the treatment of HIV, more people with HIV/AIDS in the United States worldwide will live near-normal life spans, increasing the demand for HIV care and care for comorbidities associated with aging. Concomitantly, the first generation of HIV clinicians are retiring from...
As widely described since the first phases of the pandemic, immunocompromised individuals are at higher risk of developing prolonged SARS-CoV-2 infection with respect to the general population [1, 2, 3, 4, 5–6]. This fragile population cannot efficiently respond to vaccination and is impaired in...
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection causes coronavirus disease 2019 (COVID-19). The SARS-CoV-2 virus enters target host cells through the angiotensin-converting enzyme 2 (ACE2) or cellular transmembrane serine protease 2 (TMPRSS2) route [1, 2–3]. These route are...
Telemedicine is used in a multitude of settings to fill in various gaps in healthcare. These include the opportunity to overcome geographic limitations of health care delivery for patients who do not have adequate transportation. The theory behind telemedicine is that it may increase adherence to medications...